Christoph Westphal Resigns as Sirtris Pharmaceuticals (SIRT) CEO, Takes Over GlaxoSmithKline (GSK)'s SR One Venture Arm  
4/22/2010 7:12:58 AM

Xconomy -- Christoph Westphal is leaving his CEO job at Sirtris Pharmaceuticals, the Cambridge, MA-based developer of drugs that target genes linked to the aging process, to get back into the venture capital game, according to an e-mail Westphal sent to friends and colleagues as well as Xconomy.